F orce development in smooth muscle is dependent on Ca 2ϩ /calmodulin (Ca 2ϩ /CaM) activation of myosin light chain kinase (MLCK) and the subsequent phosphorylation of the regulatory myosin light chain (MLC 20 ). 1 However, when smooth muscle is stimulated with agonists 2 or by direct activation of the G-proteins, 3-6 a higher force is developed for a given [Ca 2ϩ ] than for depolarization. Although the mechanism for this Ca 2ϩ sensitization of the contractile filaments is still the subject of investigation, evidence suggests that the signaling pathway may involve either the activation of Rho (for reviews see [7] [8] [9] ) and/or protein kinase C (PKC), 10,11 although a pathway involving Rho and subsequent activation of Rho-kinase is more widely accepted. Agonist stimulation of smooth muscle can be divided into two phases: an initial rapid, transient increase in Ca 2ϩ and MLC 20 phosphorylation, and a subsequent phase of a sustained force despite lower levels of Ca 2ϩ and MLC 20 phosphorylation. 12 There is evidence that the sustained phase of force maintenance is dependent on the activation of Rho. 13 Although uncertainty exists regarding the mechanism by which receptor-mediated activation of the G-proteins leads to force enhancement, it is generally accepted that membrane depolarization leads to an increase in intracellular [Ca 2ϩ ] and a Ca 2ϩ -dependent activation of MLCK to increase MLC 20 phosphorylation and force. Thus, it has become dogma that depolarization leads to only an increase in Ca 2ϩ and a subsequent activation of MLCK, without the activation of additional signaling pathways. Challenging these generally accepted principles is recent evidence that Rho-kinase inhibition almost completely eliminates the sustained portion of the phasic force response to 60 mmol/L KCl depolarization in rat tail artery without affecting the Ca 2ϩ transient. 14 The reduction in force was accompanied by a decrease in MLC 20 phosphorylation. These results suggest that Rho-kinase is activated during depolarization of smooth muscle, and its activation leads to an inhibition of MLC phosphatase activity.
F orce development in smooth muscle is dependent on Ca 2ϩ /calmodulin (Ca 2ϩ /CaM) activation of myosin light chain kinase (MLCK) and the subsequent phosphorylation of the regulatory myosin light chain (MLC 20 ). 1 However, when smooth muscle is stimulated with agonists 2 or by direct activation of the G-proteins, [3] [4] [5] [6] a higher force is developed for a given [Ca 2ϩ ] than for depolarization. Although the mechanism for this Ca 2ϩ sensitization of the contractile filaments is still the subject of investigation, evidence suggests that the signaling pathway may involve either the activation of Rho (for reviews see [7] [8] [9] ) and/or protein kinase C (PKC), 10, 11 although a pathway involving Rho and subsequent activation of Rho-kinase is more widely accepted. Agonist stimulation of smooth muscle can be divided into two phases: an initial rapid, transient increase in Ca 2ϩ and MLC 20 phosphorylation, and a subsequent phase of a sustained force despite lower levels of Ca 2ϩ and MLC 20 phosphorylation. 12 There is evidence that the sustained phase of force maintenance is dependent on the activation of Rho. 13 Although uncertainty exists regarding the mechanism by which receptor-mediated activation of the G-proteins leads to force enhancement, it is generally accepted that membrane depolarization leads to an increase in intracellular [Ca 2ϩ ] and a Ca 2ϩ -dependent activation of MLCK to increase MLC 20 phosphorylation and force. Thus, it has become dogma that depolarization leads to only an increase in Ca 2ϩ and a subsequent activation of MLCK, without the activation of additional signaling pathways. Challenging these generally accepted principles is recent evidence that Rho-kinase inhibition almost completely eliminates the sustained portion of the phasic force response to 60 mmol/L KCl depolarization in rat tail artery without affecting the Ca 2ϩ transient. 14 The reduction in force was accompanied by a decrease in MLC 20 phosphorylation. These results suggest that Rho-kinase is activated during depolarization of smooth muscle, and its activation leads to an inhibition of MLC phosphatase activity.
In this issue of Circulation Research, Sakurada et al 15 extend and further delineate the mechanism by which inhibition of Rho-kinase depresses force during depolarization. During both agonist and KCl depolarization of rabbit aortic smooth muscle, these investigators demonstrated that the GTP-bound active form of Rho increases in a concentrationdependent manner and the inhibition of Rho-kinase with either Y27632 or HA1077 reduced force and MLC 20 phosphorylation with similar concentration dependencies. These results suggest not only that Rho is activated during depolarization but that its activation increases force. Additionally, the group demonstrated that activation of Rho during KCl depolarization requires transmembrane Ca 2ϩ flux and results in phosphorylation of the myosin binding subunit (MYPT1) of MLC phosphatase at Thr 695 . MYPT1 phosphorylation at this site has been previously demonstrated to inhibit MLC phosphatase activity, 16 resulting in an increase in MLC 20 phosphorylation and force. 6, 17 Taken together, the data suggest that depolarization leads to an activation of Rho, Rhokinase, and subsequent MYPT1 phosphorylation resulting in an inhibition of MLC phosphatase activity and Ca 2ϩ sensitization, similar to the pathway suggested for agonist-induced force enhancement. 6, 17 This Ca 2ϩ -dependent activation of Rho is a novel finding and establishes a dual role for Ca 2ϩ /CaM: activation of MLCK and inhibition of MLC phosphatase, both of which will lead to an increase in the level of MLC 20 phosphorylation (Figure) . This signaling pathway probably requires an intact cell membrane and thus would not be present in permeabilized and/or skinned preparations, explaining the absence of an effect of Rho-kinase inhibition on Ca 2ϩ activation of skinned smooth muscle strips. 18, 19 However, Ca 2ϩ activation of Rho is consistent with the observations that in permeabilized vascular smooth muscle, Ca 2ϩ induces a translocation of Rho to the membrane 20 and the inhibition of force produced by depolarization when Rho is inactivated. 21 It has been demonstrated that the magnitude of the change in MLC 20 phosphorylation produced by depolarization is less than that produced by agonist stimulation for any given level of intracellular Ca 2ϩ . 2, 4, 6, 22, 23 This suggests that either depolarization only results in a Ca 2ϩ -dependent activation of MLCK or the inhibition of MLC phosphatase activity produced by depolarization is significantly less than produced by agonist activation. The results discussed above 14, 15 would argue for the latter. However if Rho-kinase inhibition produces similar decreases of force during activation by both
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From the Departments of Physiology and Biophysics, and Medicineagonists and depolarization, 15 it is unclear how MLC 20 phosphorylation can differ for the two forms of activation. One possibility is that there could be an additional factor required in the signaling pathway for the Ca 2ϩ -dependent activation of Rho. Sakurada et al 15 have data that could implicate Ca 2ϩ / CaM-dependent protein kinase II (CAMKII). The CAMKII inhibitor KN93 depressed both force and Rho activation during membrane depolarization but had no effect on the activation of Rho or increase in force produced by ionomycin. These results could argue that for depolarization, transmembrane Ca 2ϩ flux and either transmembrane signaling or signaling at the smooth muscle cell membrane is required for the subsequent activation of the Rho pathway.
Tissue-specific expression of a protein(s) required for this signaling cascade could explain the differences in the magnitude of Rho inhibition observed for different forms of smooth muscle activation. Changes in the level of MYPT1 phosphorylation have been shown to be tissue, 13, 17, 24 agonist, 25 and MYPT1 isoform 19 specific. Additionally, the expression of both MYPT1 isoforms 26 and the MLC phosphatase inhibitor CPI-17 27 is tissue specific. These results could suggest that a Ca 2ϩ /CaM-dependent inhibition of MLC phosphatase is also tissue specific. It is possible that the Ca 2ϩ -induced translocation of Rho to the membrane 20 occurs in all smooth muscle, but the subsequent activation of Rho requires the expression of another protein(s). Whether the activation of Rho requires G q , as suggested by Sakurada et al, 15 or some other factor is unclear, but the elucidation of the mechanism for Ca 2ϩ -dependent activation of Rho will require further studies.
The Rho/Rho-kinase signaling pathway is not only important for the regulation of smooth muscle contractility but also for other regulatory processes. Activation of the Rho/Rhokinase pathway has been demonstrated to mediate actin organization and remodeling of the cytoskeleton in nonmuscle cells. 28, 29 During integrin-mediated signaling in Rat1 cells, evidence suggests that there is a Rho dependence of focal adhesion kinase and paxillin phosphorylation, and that the formation of large focal adhesions from which actin stress fibers radiate during cell spreading and membrane ruffling is dependent on the activation of Rho. 29 In addition, in smooth muscle, data suggest that paxillin phosphorylation may participate in force maintenance. 30 The results reported by Sakurada et al 15 thus implicate Ca 2ϩ both in the mechanism for integrin signaling and reorganization of the smooth muscle cytoskeleton.
The results of this study 15 establish a dual role for Ca 2ϩ in the regulation of smooth muscle contraction, activation of MLCK, and a Rho-mediated inhibition of MLC phosphatase. The inhibition of MLC phosphatase would produce a Ca 2ϩ sensitization, a phenomenon that was previously thought to be restricted to only receptor-mediated forms of smooth muscle activation. The inhibition of MLC phosphatase activity has been implicated in the pathogenesis of hypertension 31 and in the migration of malignant cells. 32 Further, the activation of Rho is important in the regulation of cell morphology. 28, 29 Therefore, the regulation of Rho and its signaling pathway promises to be an active area of investigation.
Proposed signaling pathways involved in the regulation of smooth muscle contraction. Depolarization (right side) increases intracellular Ca 2ϩ to activate both MLCK, and also Rho, possibly via CAMKII, leading to an inhibition of MLC phosphatase activity. Agonist stimulation (left side) activates G-protein-dependent pathways, which lead to an increase in Ca 2ϩ and activation of MLCK, and also Rho activation, leading to an inhibition of MLC phosphatase (see text for details). The abbreviations not defined in the text are as follows: PLC, phospholipase C; PIP 2 , 4,5-inositol bisphosphate; DAG, diacylglycerol; IP 3 , inositol trisphosphate; GEF, guanine nucleotide exchange factors; the activated form of Rho-kinase, Rho-kinase*; and the MLC phosphatase is a trimeric complex consisting of an MYPT1, catalytic subunit (␦) and a 20-kDa subunit of unknown function.
